← Back to Search

LEAP for Alcohol Use Disorder (LEAP Trial)

N/A
Waitlist Available
Led By Seema L Clifasefi, PhD MSW
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months prior to baseline through 12-month follow-up
Awards & highlights

LEAP Trial Summary

This trial is testing a program (LEAP) to decrease alcohol use and its related harms among people experiencing chronic homelessness. LEAP is a low-barrier, community-level, house-wide resident program that includes leadership opportunities, activities, and pathways to recovery.

Who is the study for?
This trial is for current DESC clients living in certain Housing First sites who have a history of chronic homelessness and at-risk drinking. To join, men must score over 3 and women over 2 on the AUDIT-C screening. Participants must be able to consent to research and not pose a safety risk.Check my eligibility
What is being tested?
The LEAP program is being tested as an adjunct to Housing First housing. It's a community-based initiative offering leadership opportunities, activities, and recovery pathways aimed at reducing alcohol use and related harm while improving engagement in meaningful activities.See study design
What are the potential side effects?
Since LEAP is a behavioral intervention rather than a medication, it does not have traditional side effects. However, participants may experience changes in social dynamics or personal challenges as they engage with the program's activities.

LEAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months prior to baseline through 12-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months prior to baseline through 12-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol and Substance-use Frequency Assessment
Costs associated with healthcare and criminal justice service utilization
EtG Presence
+3 more
Secondary outcome measures
Attendance at Other Treatment and Mutual-Help Groups
General Quality of Life
Health-Related Quality of Life
Other outcome measures
Adult Resilience Measure-Revised (ARM-R)
Meaningful Activities Participation
Site-Specific Activity Participation

LEAP Trial Design

2Treatment groups
Active Control
Group I: LEAPActive Control1 Intervention
Housing First plus LEAP
Group II: Service-As-UsualActive Control1 Intervention
Housing First

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
800 Previous Clinical Trials
1,362,836 Total Patients Enrolled
University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,777 Total Patients Enrolled
Washington State UniversityOTHER
101 Previous Clinical Trials
56,553 Total Patients Enrolled

Media Library

LEAP Clinical Trial Eligibility Overview. Trial Name: NCT04302740 — N/A
Alcohol Use Disorder Research Study Groups: LEAP, Service-As-Usual
Alcohol Use Disorder Clinical Trial 2023: LEAP Highlights & Side Effects. Trial Name: NCT04302740 — N/A
LEAP 2023 Treatment Timeline for Medical Study. Trial Name: NCT04302740 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment for this research project still open?

"According to clinicaltrials.gov, this trial is not recruiting any more patients. This study was initially made public on February 21st 2020 and underwent its last update November 15th 2022; nevertheless, there are 260 other medical trials presently searching for participants in need of treatment options."

Answered by AI
~17 spots leftby Nov 2024